Neely T D A, Tan C J, Irwin S T
Department of Colorectal Surgery, Belfast Health and Social Care Trust, Belfast, UK.
Ulster Med J. 2017 Sep;86(3):172-176. Epub 2017 Sep 12.
Surgery is the mainstay of treatment for invasive rectal cancer. Advances in surgical technique and radiotherapy over the past few decades have resulted in improved local control and survival. Some concern remains regarding the morbidity associated with performing surgery within a short window following radiotherapy. The current study assessed whether the interval between short-course radiotherapy and surgery influences all cause post-operative morbidity and mortality.
All patients who had undergone short-course radiotherapy for rectal cancer within the Belfast Health and Social Care Trust from 2005 to 2014 held on a prospective database were included (n=102). A retrospective review of patients' clinical records was performed and a comparison made of patients who had undergone surgery less than 4 days with those 4 or more days following completion of radiotherapy. Baseline patient and tumour characteristics, post-operative complications and readmission rates were compared. Statistical analysis was performed using SPSS ®, Version 22 (SPSS, Inc, Chicago, Illinois, USA).
There was no significant difference in mortality or overall post-operative complications between groups, however, less serious complications were reduced in patients undergoing surgery less than 4 days following radiotherapy. Perineal wound complications were significantly more common in patients who had undergone surgery 4 or more days following radiotherapy.
Our results support the existing data that post-operative complications may be more common with increasing interval to surgery from completion of radiotherapy. Perineal wound morbidity appears significantly more common in patients who undergo surgery 4 or more days following short-course radiotherapy. A larger study to look particularly at perineal wound morbidity and interval from completion of radiotherapy is warranted.
手术是浸润性直肠癌治疗的主要手段。过去几十年手术技术和放疗的进展已使局部控制和生存率得到改善。对于在放疗后短时间内进行手术相关的发病率仍存在一些担忧。本研究评估短程放疗与手术之间的间隔是否会影响术后全因发病率和死亡率。
纳入2005年至2014年在贝尔法斯特健康和社会护理信托基金接受直肠癌短程放疗并记录在前瞻性数据库中的所有患者(n = 102)。对患者的临床记录进行回顾性分析,并比较放疗结束后手术时间少于4天和4天或更长时间的患者。比较患者的基线特征、肿瘤特征、术后并发症和再入院率。使用SPSS®22版(SPSS公司,伊利诺伊州芝加哥,美国)进行统计分析。
两组之间的死亡率或总体术后并发症无显著差异,然而,放疗后少于4天进行手术的患者中较轻的并发症有所减少。放疗后4天或更长时间进行手术的患者会阴部伤口并发症明显更常见。
我们的结果支持现有数据,即随着放疗结束至手术间隔时间的增加,术后并发症可能更常见。在短程放疗后4天或更长时间进行手术的患者中,会阴部伤口发病率似乎明显更常见。有必要进行一项更大规模的研究,特别关注会阴部伤口发病率和放疗结束后的间隔时间。